Trial: Amgen 20090482
Randomized, Double-Blind Multicenter Study of Denosumab Compared with Zoledronic Acid in the Treatment of Bone Disease in subjects with Newly Diagnosed Multiple Myeloma
Trial: GENENTECH ML 28257
An observational Cohort Study of Treatment Patterns and Outcomes in Patients with HER2 Positive Metastatic Breast Cancer.
Trial: AMGEN 20110147
Randomized, Phase 2 study to estimate the effect of prophylactic intervention with naproxen or loratadine on bone pain in breast cancer subjects receiving chemotherapy and pegfilgrastim
Website for all clinical trials: www.clinicaltrials.gov
If you require assistance navigating this website, or want more information about our clinical trials, please contact research manager Corilynn Hughes, R.N., B.S.N., O.C.N., at 410-871-6400.